Table 2.

Results of univariate analysis evaluating the effect of each predictive variable on visual field mean deviation (MD) measurement at baseline and MD change over time (slope) in primary angle closure glaucoma eyes

	Effect on Baseline MD		Effect on MD Slope
	Coefficient ± SE	P	Coefficient ± SE	P
Age	0.10 ± 0.13	0.45	−0.02 ± 0.01	0.04
Gender (Male as ref)	2.94 ± 2.47	0.23	0.25 ± 0.18	0.16
Hypertension	3.23 ± 2.47	0.19	−0.44 ± 0.17	0.01
Diabetes Mellitus	−0.42 ± 2.49	0.87	−0.44 ± 0.16	0.01
Central corneal thickness	−0.01 ± 0.03	0.84	<0.001 ± 0.002	0.98
Mean IOP during follow-up	0.48 ± 0.36	0.19	−0.01 ± 0.03	0.86
IOP SD during follow-up	−0.82 ± 0.83	0.32	−0.09 ± 0.06	0.18
Number of anti-glaucoma medications	−1.15 ± 0.95	0.22	−0.23 ± 0.07	0.001
Follow-up duration	0.79 ± 0.54	0.14	−0.05 ± 0.04	0.15
Retinal nerve fiber layer thickness	0.40 ± 0.05	<0.001	0.01 ± 0.01	0.14
Ganglion cell complex thickness	0.31 ± 0.06	<0.001	0.01 ± 0.01	0.06
wiVD disc	0.76 ± 0.06	<0.001	0.03 ± 0.01	0.02
wiVD macula	1.04 ± 0.20	<0.001	0.05 ± 0.02	0.02
Presence of MvD	−9.96 ± 1.60	<0.001	−0.21 ± 0.18	0.26

SE: standard error; IOP: intraocular pressure; SD: standard deviation; wiVD: whole image vessel density; MvD: Parapapillary deep-layer microvascular dropout. Optical coherence tomography examinations were performed at the last VF examination visit.